Effect of ticlopidine on saphenous vein bypass patency rates: a double-blind study.

[1]  M. Pfisterer,et al.  Accuracy of Serial Myocardial Perfusion Scintigraphy with Thallium‐20 for Prediction of Graft Patency Early‐ and Late After Coronary Artery BypassSurgery A ControlHbd Prospective Study , 1982, Circulation.

[2]  A. Landais,et al.  [Drug inhibition and lactation]. , 1982, Therapie.

[3]  H. Baur,et al.  Effects of sulfinpyrazone on early graft closure after myocardial revascularization. , 1982, The American journal of cardiology.

[4]  J. David,et al.  Pharmacological Control of Platelet and Red Blood Cell Function in the Microcirculation , 1981, Journal of cardiovascular pharmacology.

[5]  L. Becker,et al.  Stress thallium-201 myocardial scintigraphy for the detection of individual coronary arterial lesions in patients with and without previous myocardial infarction. , 1981, The American journal of cardiology.

[6]  G. Taylor,et al.  Critical Analysis of the Preoperative and Operative Predictors of Aortocoronary Bypass Patency , 1981, Annals of surgery.

[7]  J. Mayer,et al.  Influence of aspirin and dipyridamole on patency of coronary artery bypass grafts. , 1981, The Annals of thoracic surgery.

[8]  B. H. Bulkley.  Changes in late coronary artery bypass grafts: The variability of their intimal atherosclerosis , 1981 .

[9]  J. Roth,et al.  Improved graft patency with antiplatelet drugs in patients treated for one year following coronary bypass surgery , 1981 .

[10]  S. Rahimtoola,et al.  Antithrombotic therapy for saphenous vein bypass grafts. , 1980, American heart journal.

[11]  M. Bousser,et al.  Effects of long term administration of ticlopidine on platelet function and hemostatic variables. , 1980, Thrombosis research.

[12]  L. Becker,et al.  Value and Limitations of Segmental Analysis of Stress Thallium Myocardial Imaging for Localization of Coronary Artery Disease , 1980, Circulation.

[13]  Y. Abiko,et al.  Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats. , 1980, Thrombosis research.

[14]  P. Rigo,et al.  Stress thallium-201 myocardial scintigraphy. Review of methodological problems and proposal for standardization. , 1980, European heart journal.

[15]  S. Rahimtoola,et al.  Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study. , 1979, The New England journal of medicine.

[16]  M. Lagarde,et al.  Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production. , 1979, Prostaglandins and medicine.

[17]  Y. Abiko,et al.  Mode of Action of Ticlopidine in Inhibition of Platelet Aggregation in the Rat , 1979, Thrombosis and Haemostasis.

[18]  N. Aoki,et al.  Clinical Pharmacology of a New Antithrombotic Agent, Ticlo , 1978 .

[19]  Y. Abiko,et al.  Effect of ticlopidine and acetylsalicylic acid on generation of prostaglandin I2-like substance in rat arterial tissue. , 1978, Thrombosis research.

[20]  M. Etherington,et al.  Ticlopidine - an antiplatelet drug: effects in human volunteers. , 1978, Thrombosis research.

[21]  J. Barboriak,et al.  The Spectrum of Pathologic Changes in Aortocoronary Saphenous Vein Grafts , 1977, Circulation.

[22]  J. S. Cole,et al.  The pulsed Doppler coronary artery catheter preliminary report of a new technique for measuring rapid changes in coronary artery flow velocity in man. , 1977, Circulation.

[23]  R. Ross,et al.  The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.

[24]  J. Blanchard,et al.  Effects of ticlopidine, a new platelet aggregation inhibitor in man , 1975, Clinical pharmacology and therapeutics.

[25]  M. Bourassa,et al.  Postoperative Changes in Aortocoronary Saphenous Vein Grafts Revisited: Angiographic Studies at Two Weeks and at One Year in Two Series of Consecutive Patients , 1975, Circulation.

[26]  R. Frye,et al.  Pathologic changes in aortocoronary saphenous vein grafts. , 1974, The American journal of cardiology.

[27]  R. Ross,et al.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Bourassa,et al.  Angiographic Changes in Aortocoronary Vein Grafts: Lack of Progression Beyond the First Year , 1973, Circulation.

[29]  C Meere,et al.  Aortocoronary Bypass Graft: Initial Blood Flow through the Graft, and Early Postoperative Patency , 1971, Circulation.

[30]  V. Fuster,et al.  Drug trials in prevention of occlusion of aorta--coronary artery vein grafts. , 1982, The Journal of thoracic and cardiovascular surgery.

[31]  M. Marty,et al.  Toxicité hématologique de la ticlopidine , 1982 .

[32]  S. Gates,et al.  The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts. , 1982, The Journal of thoracic and cardiovascular surgery.

[33]  J. Sixma,et al.  The effect of ticlopidine administration to humans on the binding of adenosine diphosphate to blood platelets. , 1980, Thrombosis research.

[34]  J. Heywood,et al.  Possible Mode of Action of Ticlopidine: A Novel Inhibitor of Platelet Aggregation , 1979, Thrombosis and Haemostasis.

[35]  P. L. Walton,et al.  Inhibition of Intimal Proliferation of Rabbit Aorta by Ticlopidine , 1979, Thrombosis and Haemostasis.

[36]  J. Knudsen,et al.  The effect of ticlopidine on platelet function in normal volunteers and in patients with platelet hyperaggregability in vitro. , 1979, Thrombosis research.

[37]  J. David,et al.  Compared effects of three dose-levels of ticlopidine on platelet function in normal subjects. , 1979, Thrombosis research.